Related Experiment Video
Updated: May 21, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
[Effects of early treatment on physical and intelligence development in children with congenital hypothyroidism]
Yan-Hong Lu1, Xiao-Ying Liu, Yuan Song
1Department of Child Health Care, Suzhou Municipal Hospital, Suzhou, Jiangsu 215002, China.
Insights
Early thyroid hormone treatment for congenital hypothyroidism (CH) improves infant physical and intelligence development. Starting treatment before 1 month of age yields better outcomes compared to starting between 1 to 3 months.
Area of Science:
- Pediatrics
- Endocrinology
- Developmental Biology
Context:
- Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
- Neonatal screening allows for early diagnosis of CH.
- Timely intervention is crucial for preventing developmental deficits.
Purpose:
- To investigate the impact of early thyroid hormone treatment initiation on the developmental outcomes of infants with CH.
- To compare intelligence and physical development in children with CH treated before versus after 1 month of age.
Summary:
- A study followed 49 infants with CH diagnosed via neonatal screening.
- Infants were divided into two groups based on treatment initiation: <1 month and 1-3 months.
- Physical growth and intelligence were assessed at 6 months, 1 year, and 2 years. No significant differences in thyroid hormone levels were observed between groups.
- The group treated before 1 month showed significantly better height, weight, and intelligence at 6 months, with sustained physical benefits.
Impact:
- Early initiation of thyroid hormone therapy (before 1 month) is associated with enhanced physical growth and cognitive development in infants with CH.
- This finding underscores the critical window for intervention in CH management.
- Optimizing treatment timing can lead to improved long-term developmental trajectories for children with CH.
Objective:
To compare differences in the intelligence and physical developmental levels of children with congenital hypothyroidism (CH) who received initial treatment at different times.
Methods:
Forty-nine children with CH diagnosed by neonatal screening between September 2008 and September 2011 were enrolled in this study. According to the timing of initial treatment with thyroid hormone, they were classified into two groups: <1 month and 1 to 3 months of life. At 6 months old, 1 year and 2 years old, their intelligence levels were evaluated by Gessell test. Their physical developmental levels were also measured. Their thyroid functions were examined with fluorescence immunoassay.
Results:
With treatment, there were no significant differences in thyroid hormones (FT3, FT4 and TSH) between the two groups (P>0.05) at 6 months old, 1 year and 2 years old. However, heights and weights in the <1 month treatment group were significantly higher than in the 1 to 3 months treatment group at all time points (P<0.05). At 6 months old, intelligence developmental levels in the <1 month treatment group were better than the 1 to 3 months treatment group (P<0.05) but significant differences were not noted at 1 and 2 years old (P>0.05).
Conclusions:
The timing of initial treatment with thyroid hormone appears to be associated with the intelligence and physical development in children with CH. Treatment starting at less than 1 month of life contributes to improved physical and intelligence development compared with treatment starting at 1 to 3 months of life.
Related Concept Videos
Environmental Influences on Intelligence
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hypothyroidism II: Pathophysiology
Biological Influences on Intelligence
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
